Westpac Banking Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.42M | Buy |
9,604
+2,716
| +39% | +$2.08M | 0.52% | 38 |
|
|
2025
Q4 | $5.32M | Buy |
6,888
+6,073
| +745% | +$4.12M | 0.34% | 73 |
|
|
2025
Q3 | $458K | Hold |
815
| – | – | 0.03% | 265 |
|
|
2025
Q2 | $428K | Sell |
815
-16
| -2% | -$8.93K | 0.03% | 268 |
|
|
2025
Q1 | $527K | Sell |
831
-158
| -16% | -$109K | 0.04% | 253 |
|
|
2024
Q4 | $704K | Hold |
989
| – | – | 0.05% | 257 |
|
|
2024
Q3 | $1.04M | Buy |
989
+66
| +7% | +$73.4K | 0.07% | 226 |
|
|
2024
Q2 | $970K | Buy |
923
+80
| +9% | +$77.6K | 0.08% | 198 |
|
|
2024
Q1 | $811K | Sell |
843
-18
| -2% | -$17.1K | 0.06% | 219 |
|
|
2023
Q4 | $756K | Buy |
861
+163
| +23% | +$134K | 0.06% | 222 |
|
|
2023
Q3 | $574K | Sell |
698
-2,828
| -80% | -$2.22M | 0.04% | 290 |
|
|
2023
Q2 | $2.53M | Sell |
3,526
-12,248
| -78% | -$9.44M | 0.18% | 153 |
|
|
2023
Q1 | $13M | Sell |
15,774
-3,096
| -16% | -$2.34M | 0.17% | 154 |
|
|
2022
Q4 | $13.6M | Buy |
18,870
+9,646
| +105% | +$7.12M | 0.2% | 134 |
|
|
2022
Q3 | $6.35M | Sell |
9,224
-405
| -4% | -$255K | 0.1% | 276 |
|
|
2022
Q2 | $5.69M | Sell |
9,629
-6,233
| -39% | -$4.05M | 0.07% | 336 |
|
|
2022
Q1 | $11.1M | Sell |
15,862
-12,161
| -43% | -$7.69M | 0.13% | 220 |
|
|
2021
Q4 | $17.7M | Buy |
28,023
+4,963
| +22% | +$3.05M | 0.18% | 137 |
|
|
2021
Q3 | $14M | Sell |
23,060
-9,447
| -29% | -$5.86M | 0.15% | 175 |
|
|
2021
Q2 | $18.2M | Buy |
32,507
+7,613
| +31% | +$3.86M | 0.18% | 141 |
|
|
2021
Q1 | $11.8M | Buy |
24,894
+9,512
| +62% | +$4.63M | 0.13% | 205 |
|
|
2020
Q4 | $7.43M | Buy |
15,382
+939
| +7% | +$507K | 0.08% | 305 |
|
|
2020
Q3 | $8.08M | Sell |
14,443
-1,147
| -7% | -$695K | 0.11% | 248 |
|
|
2020
Q2 | $9.72M | Sell |
15,590
-4,476
| -22% | -$2.54M | 0.14% | 176 |
|
|
2020
Q1 | $9.8M | Sell |
20,066
-2,268
| -10% | -$936K | 0.17% | 157 |
|
|
2019
Q4 | $8.39M | Buy |
22,334
+14,896
| +200% | +$5.01M | 0.11% | 268 |
|
|
2019
Q3 | $2.06M | Sell |
7,438
-1,510
| -17% | -$447K | 0.03% | 512 |
|
|
2019
Q2 | $2.8M | Buy |
8,948
+3,383
| +61% | +$1.13M | 0.04% | 403 |
|
|
2019
Q1 | $2.29M | Buy |
5,565
+509
| +10% | +$210K | 0.04% | 416 |
|
|
2018
Q4 | $1.89M | Hold |
5,056
| – | – | 0.03% | 466 |
|
|
2018
Q3 | $2.04M | Hold |
5,056
| – | – | 0.04% | 431 |
|
|
2018
Q2 | $1.74M | Sell |
5,056
-17,892
| -78% | -$5.6M | 0.03% | 411 |
|
|
2018
Q1 | $7.9M | Buy |
22,948
+4,992
| +28% | +$1.74M | 0.16% | 198 |
|
|
2017
Q4 | $6.75M | Buy |
17,956
+1,000
| +6% | +$405K | 0.15% | 192 |
|
|
2017
Q3 | $7.58M | Buy |
16,956
+11,769
| +227% | +$5.6M | 0.17% | 183 |
|
|
2017
Q2 | $2.55M | Sell |
5,187
-784
| -13% | -$343K | 0.06% | 372 |
|
|
2017
Q1 | $2.31M | Buy |
5,971
+1,230
| +26% | +$456K | 0.02% | 539 |
|
|
2016
Q4 | $1.68M | Hold |
4,741
| – | – | 0.02% | 503 |
|
|
2016
Q3 | $1.91M | Buy |
4,741
+480
| +11% | +$193K | 0.02% | 473 |
|
|
2016
Q2 | $1.49M | Buy |
4,261
+1,001
| +31% | +$386K | 0.02% | 545 |
|
|
2016
Q1 | $1.18M | Sell |
3,260
-2,465
| -43% | -$1.02M | 0.01% | 529 |
|
|
2015
Q4 | $3.11M | Buy |
5,725
+2,473
| +76% | +$1.34M | 0.03% | 387 |
|
|
2015
Q3 | $1.51M | Buy |
3,252
+2,764
| +566% | +$1.48M | 0.02% | 480 |
|
|
2015
Q2 | $249K | Sell |
488
-4,227
| -90% | -$2.06M | ﹤0.01% | 639 |
|
|
2015
Q1 | $2.39M | Sell |
4,715
-231
| -5% | -$97.9K | 0.02% | 480 |
|
|
2014
Q4 | $2.03M | Sell |
4,946
-372
| -7% | -$146K | 0.02% | 499 |
|
|
2014
Q3 | $1.92M | Buy |
5,318
+59
| +1% | +$19.8K | 0.02% | 503 |
|
|
2014
Q2 | $1.49M | Hold |
5,259
| – | – | 0.01% | 545 |
|
|
2014
Q1 | $1.58M | Buy |
5,259
+500
| +11% | +$154K | 0.02% | 502 |
|
|
2013
Q4 | $1.31M | Sell |
4,759
-31
| -0.6% | -$8.92K | 0.02% | 538 |
|
|
2013
Q3 | $1.5M | Sell |
4,790
-192
| -4% | -$50.5K | 0.02% | 495 |
|
|
2013
Q2 | $1.04M | Buy |
+4,982
| New | +$1.16M | 0.02% | 546 |
|
Other funds holding REGN
VCM
N
Westpac Banking Corp's REGN Position: Q1 2026 in Review
Westpac Banking Corp increased its Regeneron Pharmaceuticals (REGN) stake by 39% in Q1 2026, buying an estimated $2.08M and bringing the position to 9,604 shares worth $7.42M. The position accounts for 0.52% of the portfolio, ranked #38.
Westpac Banking Corp first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.2M in Q2 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Westpac Banking Corp held 9,604 shares of Regeneron Pharmaceuticals worth $7.42M as of Q1 2026.
- Westpac Banking Corp bought 2,716 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.08M.
- Regeneron Pharmaceuticals made up 0.52% of Westpac Banking Corp's portfolio in Q1 2026, its #38 holding.
- Westpac Banking Corp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Westpac Banking Corp's Regeneron Pharmaceuticals position peaked at $18.2M in Q2 2021.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.